当前位置:首页 - 行情中心 - 泰林生物(300813) - 财务分析

泰林生物

(300813)

  

流通市值:15.19亿  总市值:24.20亿
流通股本:7605.11万   总股本:1.21亿

泰林生物(300813)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2025年第一季度实现净利润0.03亿元,每股收益0.03元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2025年第一季度最新股东权益82357.85万元,未分配利润25424.28万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2025年第一季度最新总资产93901.93万元,负债11544.08万元。

利润表
报告期2025-03-312024-12-312024-09-302024-06-30
营业总收入66,938,979.3348,998,253.03242,467,278.88156,282,129.74
营业总成本62,864,064.42348,161,065.58236,221,850.45151,988,460.49
营业利润4,047,379.9312,398,740.8512,850,755.647,454,530.2
利润总额3,518,979.7412,766,485.0112,595,272.157,208,892.54
净利润3,327,916.5212,253,626.7210,599,894.145,866,178.64
其他综合收益----
综合收益总额3,327,916.5212,253,626.7210,599,894.145,866,178.64
资产负债表
报告期2025-03-312024-12-312024-09-302024-06-30
流动资产合计614,873,640.83632,761,878.52636,321,857.58617,406,145.54
非流动资产合计324,145,683.01327,146,049.55325,767,216.59332,239,323.03
资产总计939,019,323.84959,907,928.07962,089,074.17949,645,468.57
流动负债合计112,047,540.31135,785,102.66141,271,713.73135,565,439.86
非流动负债合计3,393,283.593,393,283.59165,212,719.95163,250,484.8
负债合计115,440,823.9139,178,386.25306,484,433.68298,815,924.66
归属于母公司股东权益合计823,578,499.94820,050,345.31654,843,177.53650,069,174.73
股东权益合计823,578,499.94820,729,541.82655,604,640.49650,829,543.91
负债和股东权益合计939,019,323.84959,907,928.07962,089,074.17949,645,468.57
现金流量表
报告期2025-03-312024-12-312024-09-302024-06-30
经营活动现金流入小计70,093,446.06355,695,474.12233,795,795.59148,599,488.05
经营活动现金流出小计80,830,967.33331,038,859.93254,510,790.13175,671,155.79
经营活动产生的现金流量净额-10,737,521.2724,656,614.19-20,714,994.54-27,071,667.74
投资活动现金流入小计472,400,165.74708,157,690.05569,235,804.24377,891,894.5
投资活动现金流出小计379,891,445.61750,538,053.63540,813,362.92389,660,626.93
投资活动产生的现金流量净额92,508,720.13-42,380,363.5828,422,441.32-11,768,732.43
筹资活动现金流入小计-15,645,426.715,645,426.78,250,155.45
筹资活动现金流出小计27,343,552.7226,108,435.7910,920,399.2910,913,522.2
筹资活动产生的现金流量净额-27,343,552.72-10,463,009.094,725,027.41-2,663,366.75
汇率变动对现金及现金等价物的影响22,175.92135,328.6-151,083.968,903.77
现金及现金等价物净增加额54,449,822.06-28,051,429.8812,281,390.29-41,434,863.15
期末现金及现金等价物余额124,327,904.5269,878,082.46110,182,347.0556,494,649.19
TOP↑